White Mulberry Allergy Shots: Desert Southwest Pollen Overload Tree
White mulberry (Morus alba) is the leading tree pollen allergen in Phoenix, Tucson, El Paso, and Las Vegas — cities that planted almost exclusively male fruitless cultivars that release pollen but produce no fruit, creating an urban pollen-factory effect. Las Vegas banned new mulberry plantings in 1991.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
White Mulberryis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
White Mulberry Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to white mulberry — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of white mulberry allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of white mulberry immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of white mulberry extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for white mulberry allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing white mulberry extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription white mulberry immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat white mulberry allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is White Mulberry?
The biology, taxonomy, and clinical fingerprint of White Mulberry — the foundation of how SCIT targets it.
White mulberry male fruitless cultivars dominate Phoenix, Tucson, and Las Vegas urban landscapes — every tree releases pollen and none traps it, driving sensitization rates above 30% in these cities.
- Scientific name
- Morus alba
- Family
- MoraceaeMulberry family
- Type
- Tree pollen — wind-pollinated dioecious; male-only urban plantings concentrate exposure
- Native to
- Eastern Asia; widely naturalized across desert Southwest and urban US
- Allergen proteins
- Mor a 2 — cobalamin-independent methionine synthase (novel mulberry allergen)Mor n 3 — non-specific lipid transfer protein (nsLTP); pollen and fruit cross-reactive
- Particle size
- ~17 µm; explosive catkin dehiscence — mechanically rapid release
- Avoidance difficulty
- Nearly impossible
How White Mulberry Allergy Presents
Symptoms by body system — useful for distinguishing White Mulberry sensitivity from overlapping allergies and infections.
Respiratory
- Intense sneezing attacks from late February through May in Phoenix and Tucson
- Severe nasal congestion during the explosive March mulberry catkin dehiscence
- Rhinorrhea and post-nasal drip persisting through the April mulberry peak
- Significant allergic asthma exacerbation during peak mulberry counts
- Throat irritation from dense mulberry pollen exposure on windy March days
Ocular
- Severe watery, itchy eyes during the March–May desert Southwest mulberry season
- Intense conjunctival injection and periorbital swelling during peak mulberry counts
- Contact lens intolerance during mulberry season in Phoenix and Tucson
- Chemosis in heavily sensitized patients on extreme mulberry count days
Dermal
- Atopic dermatitis flares coinciding with the March–May mulberry pollen season
- Contact urticaria from handling mulberry fruit or foliage in Mor n 3-sensitized patients
- Oral allergy syndrome with fig, peach, or mulberry fruit consumption
Systemic
- Severe fatigue during the peak March–April mulberry pollen load in Phoenix and Tucson
- Sleep disruption from intense nasal congestion during mulberry season
- Reduced quality of life significantly impacting outdoor activities in affected cities
- Generalized malaise in patients with combined mulberry and olive pollen sensitization
Phoenix and Tucson built mulberry-driven pollen counts that don't exist anywhere east of the Mississippi. Every fruitless cultivar planted in the 1970s and 80s is a permanent male pollen factory — and our desert Southwest patients pay the price every March and April.
When & Where White Mulberry Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: March–April in the desert Southwest (Phoenix, Tucson, El Paso, Las Vegas); starting late February in the warmest years· ~10–12 weeks of pollen season; explosive catkin dehiscence makes daily counts extremely high during the March peak
US Exposure Map
4 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Low
- MT:
- Low
- ND:
- Low
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- Low
- ID:
- Low
- WY:
- Low
- SD:
- Low
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Low
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Moderate
- NV:
- High
- UT:
- Moderate
- CO:
- Moderate
- NE:
- Low
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- High
- NM:
- High
- KS:
- Low
- AR:
- None
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- Moderate
- LA:
- Moderate
- MS:
- Moderate
- AL:
- Low
- GA:
- Low
- TX:
- High
- FL:
- Low
- AK:
- Low
- HI:
- Low
What White Mulberry Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
White mulberry cross-reactivity is driven by Mor n 3 (nsLTP), which links mulberry pollen to a meaningful oral allergy syndrome with fig, peach, and mulberry fruit in sensitized patients.
Direct intra-species cross-reactivity; fruit and pollen share LTP and Mor a 2 epitopes
Moraceae family LTP cross-reactivity; fig OAS reported in Mor n 3-sensitized patients
LTP-mediated OAS; Pru p 3 and Mor n 3 cross-reactivity
Mulberry-Fig-Peach Syndrome
Mor n 3 (nsLTP) in white mulberry pollen cross-reacts with LTP proteins in fig, peach, and mulberry fruit; patients may experience oral tingling or urticaria when eating these foods during or after the March–May pollen season.
Is SCIT Right for Your White Mulberry Allergy?
Answer five questions to assess whether white mulberry SCIT fits your spring desert Southwest allergy profile.
How severe are your March–May spring allergy symptoms in your desert Southwest city?
The White Mulberry SCIT Protocol
White mulberry SCIT uses a non-standardized extract; given the extreme regional exposure in Phoenix and Tucson, some Southwest allergists apply cluster or rush protocols (clinic-only — not available through Curex) to complete build-up before the explosive March pollen onset. Curex uses a conservative once-weekly build-up schedule.
Beginning in late summer or fall, the allergist escalates from the most dilute Morus alba extract to the maintenance dose over 6–8 months via once-weekly injections. Some in-clinic allergists offer cluster or rush build-up (clinic-only — not available through Curex) to reach maintenance before the February–March pollen onset. With Curex, eligible patients run this build-up at home — the first injection from each new vial or concentration is supervised live in the Virtual Shot Room, and a 30-minute observation follows each injection.
Ongoing maintenance injections continue year-round, providing ongoing immune desensitization through successive March–May mulberry seasons. Annual symptom scoring helps track progress. With Curex, you self-inject the maintenance dose at home, with changes to a new vial or concentration supervised live in the Virtual Shot Room and a 30-minute observation after each injection.
After completing the recommended course, durable post-treatment symptom reduction is the goal. Given the permanent male-clone pollen factories in Southwest cities, ongoing exposure after treatment ends makes full clinical tolerance — rather than elimination — the realistic long-term target.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for White Mulberry SCIT
No randomized controlled trial has been published for white mulberry SCIT — a major evidence gap given its extreme regional clinical impact in the desert Southwest. Clinical prescribing follows the AAAAI/ACAAI Practice Parameter framework.
- Mulberry sensitization rate in Southwest US cities30%University of Arizona Pollen Monitoring; Levetin E. aerobiology data — sensitization exceeds 30% in mulberry-dominant cities
- Estimated symptomatic benefit from non-standardized tree SCIT (framework)50%Cox L et al., J Allergy Clin Immunol 2011;127:S1–S55 — Practice Parameter Third Update
- IgE reactivity to Mor n 3 (nsLTP) in mulberry-allergic cohorts60%WHO/IUIS Allergen Nomenclature database; Mor n 3 characterization data
White mulberry SCIT carries the paradox of extreme regional clinical importance paired with essentially no RCT evidence — one of the largest evidence gaps in US tree-pollen immunotherapy. Despite this, allergists in Phoenix and Tucson prescribe mulberry SCIT routinely as the dominant spring tree allergen in their environment. The AAAAI/ACAAI Practice Parameter (Cox 2011; Greenhawt 2023) supports its use for confirmed sensitization with inadequate pharmacotherapy response.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
White Mulberry SCIT Side Effects
White mulberry SCIT side effects follow the pattern for non-standardized inhalant tree extracts; local reactions are most common and serious systemic events are rare with proper protocols.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site erythema and swelling Most common; typically resolves within 4–8 hours | Rate 25–50% | Mild |
Injection-site pruritus Localized itching; cool compress provides relief | Rate 20–35% | Mild |
Large local reaction Swelling >5 cm; may require dose adjustment at next visit | Rate 5–10% | Moderate |
Delayed local soreness Induration 4–8 hours post-injection; typically self-limited | Rate 5–8% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis or conjunctivitis flare More likely during active March–April mulberry season injections | Rate 0.5–1% | Mild |
Urticaria Hives beyond injection site; report to your Curex care team for evaluation | Rate 0.1–0.3% | Moderate |
Mild bronchospasm Heightened risk during March peak mulberry season; pre-injection asthma assessment important | Rate 0.1–0.2% | Moderate |
Anaphylaxis Extremely rare; detected and managed during mandatory 30-minute post-injection observation | Rate <0.01% | Severe |
SCIT has traditionally been administered in a clinic equipped for emergency treatment; for eligible patients, Curex makes safe at-home self-administration possible — your Morus alba serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room, and a 30-minute observation follows each injection. This matters most for desert Southwest patients dosing during the active March–April mulberry season, when systemic reactivity may be heightened.
SCIT vs Alternatives for White Mulberry
Desert Southwest mulberry allergy management options include seasonal pharmacotherapy, avoidance (severely limited in mulberry-dominant urban landscapes), sublingual immunotherapy, and SCIT.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate (no RCT) | Comparable (extrapolated) | Nearly impossible in AZ/NV cities | Good short-term control |
| 5-yr cost | $3,500–$10,000 | Varies by provider; not Curex's product | Low | $500–$2,000/yr |
| Duration | 3–5 years | 3–5 years | Ongoing | Lifelong |
| Convenience | At-home weekly → monthly self-injection | Daily drops at home | Essentially impossible | Daily pill/spray |
| Safety | Very safe | Very safe | Excellent | Generally safe |
| Lasting effect | Yes, years post-tx | Yes, years post-tx | No | No — returns off meds |
SCITBest
SLIT
Avoidance
Medications
For confirmed white mulberry sensitization with multi-season spring symptoms in Phoenix, Tucson, or Las Vegas, SCIT is the most effective long-term option given the near-impossibility of avoidance in mulberry-dominant urban landscapes. Curex now delivers this disease-modifying SCIT at home with pricing confirmed in a current program quote for the March–May desert Southwest mulberry season — a Morus alba serum sterile-compounded to USP <797>, weekly self-injection with the first injection from each new vial or concentration supervised live in the Virtual Shot Room, and a prescribed epinephrine auto-injector confirmed on hand under board-certified allergist oversight.
What White Mulberry SCIT Actually Costs
Most major US insurers cover white mulberry SCIT under standard allergy benefits for patients in Arizona, Nevada, and New Mexico with documented positive mulberry sensitization; coverage approval is typically supported by the high regional prevalence of mulberry as a leading tree allergen in Southwest cities. Curex at-home IgE testing identifies specific white mulberry sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your white mulberry allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
White Mulberry SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
White mulberry became a dominant allergen in Phoenix, Tucson, and Las Vegas because of how the trees were planted. Beginning in the 1950s and 1960s, cities throughout the desert Southwest used almost exclusively male 'fruitless' cultivars — trees that produce no messy fruit but release enormous quantities of pollen. Because every tree in a neighborhood is male, there are no female trees to trap pollen with sticky stigmas, and the catkin dehiscence mechanism in mulberry is mechanically explosive, releasing clouds of 17-µm pollen particles into the air very rapidly. The result is airborne pollen counts in mulberry-dominated neighborhoods that can rival or exceed those of any temperate-zone tree. By 1991 Las Vegas had enough evidence of the public health burden to ban new mulberry plantings; Albuquerque and Tucson followed with restrictions. But the existing trees continue to pollinate annually.
Mor a 2 is a cobalamin-independent methionine synthase — a novel mulberry-specific pollen allergen that was formally named by the WHO/IUIS Allergen Nomenclature Sub-Committee after its characterization in Morus alba pollen. Mor n 3 is a non-specific lipid transfer protein (nsLTP) that is present in both the pollen and the fruit of mulberry, making it the molecule responsible for the cross-reactivity between mulberry pollen exposure and food OAS symptoms with fig, peach, and mulberry fruit. Additionally, a 10-kDa protein in paper mulberry (Broussonetia papyrifera) is a major allergen in Pakistan with 79% IgE reactivity in sensitized patients (Khan et al., Clin Exp Allergy 2013). These are the only formally named Moraceae pollen allergens; other IgE-binding proteins including profilin and PR-10 homologs have been reported but not separately named.
Mulberry fruit OAS is possible in patients sensitized to Mor n 3 (nsLTP), which is present in both the pollen and the fruit. Unlike the Bet v 1-mediated birch-food syndrome where cooking typically eliminates reactivity (because Bet v 1 is heat-labile), nsLTP-mediated food reactions can persist with cooked forms because nsLTP proteins are heat-stable. If you notice oral tingling, lip swelling, or throat itching after eating fresh mulberry, fig, or peach, particularly during or just after the spring pollen season, inform a board-certified allergist. Not all mulberry-pollen-sensitized patients react to mulberry fruit — Mor n 3 sensitization is a subset of total mulberry IgE reactivity — but the risk is real and worth evaluating through challenge testing if symptoms occur.
Las Vegas's 1991 Clark County ordinance banned the planting of new mulberry trees, and Albuquerque and Pima County (Tucson) followed with similar restrictions. However, existing trees were not removed — they continue to grow and pollinate for decades. Mulberry is a long-lived tree and the specimens planted in the 1960s–1980s are still productive pollen sources. The ban prevents the pollen load from growing further but does not reduce the current load from established trees. For allergy patients in Las Vegas, the practical implication is that mulberry pollen exposure remains significant and is expected to remain so for many years as the existing trees age. SCIT remains a reasonable long-term management option for confirmed mulberry sensitization in these cities.
Most patients in Phoenix and Tucson notice meaningful improvement in mulberry season symptoms after one or two full March–May seasons on the maintenance dose — typically 12–24 months into treatment. Because mulberry exposure in these cities is so intense, even partial immune desensitization from the build-up phase may provide noticeable benefit in the first mulberry season after starting shots. Full immunologic modulation develops over 2–3 years of consistent maintenance. No white mulberry-specific RCT has been published, so these timelines extrapolate from the broader non-standardized tree SCIT literature and the AAAAI/ACAAI Practice Parameter (Cox 2011).
Yes — many Southwest allergy patients are sensitized to both white mulberry (March–May) and olive pollen (April–June in California and Arizona), which are botanically unrelated but have overlapping spring seasons in desert cities. Both can be included in a multi-allergen SCIT vial protocol if sensitization to each is confirmed. The Practice Parameter (Cox 2011; Greenhawt 2023) supports combining confirmed sensitizations into pragmatic mixes. Because mulberry (Moraceae) and olive (Oleaceae) have no known major cross-reactive protein, they represent independent sensitization events that require separate extract components in the mix. A board-certified Southwest allergist can design the optimal multi-allergen spring vial for your specific sensitization profile.
Most major US health insurers cover white mulberry SCIT under standard allergy benefits when prescribed by a board-certified allergist with documented positive mulberry sensitization. In Arizona and Nevada, where mulberry is a recognized leading regional aeroallergen, prior authorization is typically straightforward with a spring allergic rhinitis or allergic asthma diagnosis code. Out-of-pocket costs over a 5-year course typically range from $3,500 to $10,000 depending on plan deductible and co-insurance. Your allergist's billing office can assist with prior authorization; insurers familiar with Southwest allergy patterns generally recognize mulberry as a clinically significant allergen warranting coverage.
Yes — white mulberry SCIT is appropriate for pediatric patients in Phoenix, Tucson, and Las Vegas with confirmed Morus alba sensitization and inadequate control on pharmacotherapy. AAAAI/ACAAI Practice Parameters support allergen immunotherapy in children typically from age 5 onward (in-clinic protocols). Curex's at-home pilot is currently open to patients age 12 and older; pediatric patients under 12 should receive SCIT through an in-clinic pediatric allergist. For eligible patients age 12 and older pursuing Curex's at-home program, a trained adult caregiver must be physically present for every injection and trained to administer epinephrine if needed. Given the intense mulberry exposure in these cities, pediatric allergists in Phoenix and Tucson routinely prescribe mulberry SCIT. Build-up dosing is adjusted for body weight and skin-test reactivity. The 30-minute post-injection observation period is mandatory and parents should be instructed in recognizing early systemic reaction signs. Reassuringly, a large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections, the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots. Southwest pediatric allergy programs typically use a pre-seasonal build-up strategy, starting in fall and targeting completion before the February–March mulberry pollen onset.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.